Skip to main content

Table 2 Non-susceptibility of MRSA isolates to tetracyclines, Antimicrobial Resistance Surveillance Network – ARS, Germany, 2010–2015

From: Decline in the proportion of methicillin resistance among Staphylococcus aureus isolates from non-invasive samples and in outpatient settings, and changes in the co-resistance profiles: an analysis of data collected within the Antimicrobial Resistance Surveillance Network, Germany 2010 to 2015

 

N MRSA isolates tested for tetracycline resistance

n (%) non-susceptible to tetracyclines

p-value

N

19 721

1 498 (8)

 

Age [years]

  

<0.001

 0–9

414

79 (19)

 

 10–19

216

45 (21)

 

 20–29

367

64 (17)

 

 30–39

436

75 (17)

 

 40–49

936

107 (11)

 

 50–59

1 883

180 (10)

 

 60–69

3 219

252 (8)

 

 70–79

6 093

357 (6)

 

 80+

6 157

339 (6)

 

Sex

  

<0.001

 Women

6 449

428 (7)

 

 Men

8 736

635 (7)

 

 Unspecified

4 536

435 (10)

 

Federal state

  

<0.001

 Baden-Württemberg

2 544

134 (5)

 

 Bavaria

336

47 (14)

 

 Berlin

1 248

84 (7)

 

 Hesse

664

40 (6)

 

 North Rhine-Westphalia

11 445

942 (8)

 

 Rhineland Palatinate

1 790

86 (5)

 

 Schleswig-Holstein

1 534

159 (10)

 

Sample type

  

<0.001

 Swabs (other than from lesions)

6 059

498 (8)

 

 Blood culture

926

43 (5)

 

 Biopsies

302

32 (11)

 

 Respiratory sample

2 538

183 (7)

 

 Urine

3 006

166 (6)

 

 Lesion

6 455

541 (8)

 

 Other

435

35 (8)

 

Type of care

  

0.016

 Outpatient care

6 668

553 (8)

 

 Intensive care unit

2 048

142 (7)

 

 Normal hospital ward

10 780

776 (7)

 

Clinical specialty

  

0.001

 Surgery

3 943

348 (9)

 

 Internal/conservative

10 645

748 (7)

 

 Other

5 133

402 (8)

 
  1. The numbers may not tally to the total due to missing data or due to a low frequency of entries, which do not fit the categories shown (i.e. for type of care and for federal state)